{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:13:16Z","timestamp":1790176396663,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.jcv.2011.01.016","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T14:22:31Z","timestamp":1299334951000},"page":"38-43","source":"Crossref","is-referenced-by-count":34,"title":["Analytical performance of Cervista\u00ae HPV 16\/18 genotyping test for cervical cytology samples"],"prefix":"10.1016","volume":"51","author":[{"given":"Deborah A.","family":"Bartholomew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Luff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B.","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn C.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcv.2011.01.016_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.jcv.2011.01.016_bib0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"Carcinogenicity of human papillomaviruses","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.jcv.2011.01.016_bib0015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jcv.2011.01.016_bib0020","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcv.2011.01.016_bib0025","doi-asserted-by":"crossref","first-page":"b2569","DOI":"10.1136\/bmj.b2569","article-title":"Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study","volume":"339","author":"Castle","year":"2009","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.jcv.2011.01.016_bib0030","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/507909","article-title":"Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer","volume":"194","author":"Wheeler","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jcv.2011.01.016_bib0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0272989X09336140","article-title":"Estimating progression rates for human papillomavirus infection from epidemiological data","volume":"30","author":"Jit","year":"2010","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.jcv.2011.01.016_bib0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.jcv.2011.01.016_bib0045","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jcv.2011.01.016_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jcv.2011.01.016_bib0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jcv.2011.01.016_bib0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2006.07.031","article-title":"Clinical utility of HPV genotyping","volume":"103","author":"Meijer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jcv.2011.01.016_bib0065","series-title":"Genified DNA extraction kit","author":"Third Wave Technologies Inc.","year":"2009"},{"issue":"15","key":"10.1016\/j.jcv.2011.01.016_bib0070","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1073\/pnas.140225597","article-title":"Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction","volume":"97","author":"Hall","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"S1","key":"10.1016\/j.jcv.2011.01.016_bib0075","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S1386-6532(09)70010-1","article-title":"Analytical performance of the Investigational Use Only Cervista\u2122 HPV HR test as determined by a multi-center study","volume":"45","author":"Day","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2011.01.016_bib0080","series-title":"Document EP17-A. Protocols for determination of limits of detection and limits of quantitation; approved guidelines","author":"Clinical and Laboratory Standards Institute","year":"2004"},{"issue":"1","key":"10.1016\/j.jcv.2011.01.016_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2011.01.016_bib0090","volume":"vol. 24.","author":"Clinical and Laboratory Standards Institute","year":"2004"},{"key":"10.1016\/j.jcv.2011.01.016_bib0095","series-title":"An in vitro diagnostic test for the detection of DNA from human papillomavirus type 16 and type 18 in cervical specimens","author":"Third Wave Technologies Inc. a subsidiary of Hologic Inc. CERVISTA\u2122 HPV 16\/18","year":"2009"},{"issue":"1","key":"10.1016\/j.jcv.2011.01.016_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.jcv.2011.01.016_bib0105","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1158\/1055-9965.EPI-10-0131","article-title":"Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy","volume":"19","author":"Carozzi","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.jcv.2011.01.016_bib0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12105-008-0048-3","article-title":"The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence","volume":"2","author":"Lawson","year":"2008","journal-title":"Head Neck Pathol"},{"issue":"2","key":"10.1016\/j.jcv.2011.01.016_bib0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2010.04.013","article-title":"Clinical validation of the Cervista HPV HR and 16\/18 genotyping tests for use in women with ASC-US cytology","volume":"118","author":"Einstein","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321100045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665321100045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:32:16Z","timestamp":1637357536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665321100045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S138665321100045X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2011.01.016","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}